FOGHORN THERAPEUTICS INC (FHTX) Stock Earnings & Estimates
USA - NASDAQ:FHTX - US3441741077 - Common Stock
4.095 USD
-0.33 (-7.35%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 19.23M 1,356.82% | 34.155M 77.61% | 22.602M -33.83% | 32.49M 43.75% | 32.904M 1.27% | 44.93M 36.55% | 59.142M 31.63% | 87.795M 48.45% | 110.34M 25.68% | 174.95M 58.56% | 250.77M 43.34% | |
| EBITDA YoY % growth | -113.84M -16.71% | -104.455M 8.24% | -97.165M 6.98% | -76.939M 20.82% | -123.373M -60.35% | -74.877M 39.31% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -117.14M -16.28% | -107.906M 7.88% | -100.285M 7.06% | -85.51M 14.73% | -91.865M -7.43% | -82.517M 10.18% | -72.608M 12.01% | -45.493M 37.35% | -19.599M 56.92% | 36.456M 286.01% | 98.241M 169.48% | |
| Operating Margin | -609.15% | -315.93% | -443.70% | -263.19% | -279.19% | -183.66% | -122.77% | -51.82% | -17.76% | 20.84% | 39.18% | |
| EPS YoY % growth | -2.62 2.96% | -2.34 10.69% | -1.65 29.49% | -1.21 26.44% | -1.14 5.88% | -1.21 -5.88% | -0.68 43.71% | -0.26 61.80% | 0.11 141.18% | 0.70 557.14% | 1.33 89.49% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.34 -9.52% | -0.26 12.57% | -0.35 -16.51% | -0.35 -23.25% | -0.34 0.26% | -0.34 -30.67% | -0.46 -31.32% | -0.47 -35.37% | -0.48 -41.27% | -0.49 -42.26% | -0.50 -8.00% | -0.51 -8.30% |
| Revenue Q2Q % growth | 5.973M -23.50% | 12.405M 334.35% | 5.95M -0.03% | 5.95M -21.27% | 8.925M 49.42% | 8.925M -28.05% | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | -29.648M -37.94% | -4.111M 80.32% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -23.211M 2.69% | -17.292M 27.97% | -29.591M -29.15% | -30.689M -45.46% | -21.718M 6.43% | -22.098M -27.80% | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.28 37.78% | -0.37 | 0.09 | 23.44% |
| Q1 2025 Q2Q % growth | -0.30 49.15% | -0.35 | 0.05 | 14.04% |
| Q4 2024 Q2Q % growth | -0.30 47.37% | -0.33 | 0.03 | 10.09% |
| Q3 2024 Q2Q % growth | -0.31 8.82% | -0.45 | 0.14 | 30.99% |
| Q2 2024 Q2Q % growth | -0.45 35.71% | -0.67 | 0.22 | 32.64% |
| Q1 2024 Q2Q % growth | -0.59 19.18% | -0.65 | 0.06 | 8.69% |
| Q4 2023 Q2Q % growth | -0.57 17.39% | -0.78 | 0.21 | 26.78% |
| Q3 2023 Q2Q % growth | -0.34 45.16% | -0.76 | 0.42 | 55.54% |
| Q2 2023 Q2Q % growth | -0.70 -6.06% | -0.75 | 0.05 | 6.63% |
| Q1 2023 Q2Q % growth | -0.73 -12.31% | -0.74 | 0.01 | 1.28% |
| Q4 2022 Q2Q % growth | -0.69 6.76% | -0.63 | -0.06 | -9.46% |
| Q3 2022 Q2Q % growth | -0.62 12.68% | -0.63 | 0.01 | 1.96% |
| Q2 2022 Q2Q % growth | -0.66 -4.76% | -0.60 | -0.06 | -9.21% |
| Q1 2022 Q2Q % growth | -0.65 -4.84% | -0.53 | -0.12 | -21.96% |
| Q4 2021 Q2Q % growth | -0.74 60.22% | -0.50 | -0.24 | -48.67% |
| Q3 2021 Q2Q % growth | -0.71 77.24% | -0.68 | -0.03 | -4.41% |
| Q2 2021 Q2Q % growth | -0.63 | -0.64 | 0.01 | 1.44% |
| Q1 2021 Q2Q % growth | -0.62 | -0.64 | 0.02 | 3.52% |
| Q4 2020 Q2Q % growth | -1.86 | -0.46 | -1.40 | -305.23% |
| Q3 2020 Q2Q % growth | -3.12 | -1.75 | -1.37 | -77.84% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 7.557M 9.71% | 6.628M | 929K | 14.02% |
| Q1 2025 Q2Q % growth | 5.952M 17.86% | 5.932M | 20K | 0.34% |
| Q4 2024 Q2Q % growth | 2.856M -50.49% | 7.483M | -4.627M | -61.83% |
| Q3 2024 Q2Q % growth | 7.808M -55.33% | 6.465M | 1.343M | 20.77% |
| Q2 2024 Q2Q % growth | 6.888M 23.02% | 6.161M | 727K | 11.80% |
| Q1 2024 Q2Q % growth | 5.05M -4.88% | 7.05M | -2M | -28.37% |
| Q4 2023 Q2Q % growth | 5.769M 38.01% | 4.714M | 1.055M | 22.38% |
| Q3 2023 Q2Q % growth | 17.478M 163.62% | 4.611M | 12.867M | 279.05% |
| Q2 2023 Q2Q % growth | 5.599M 24.70% | 6.388M | -789K | -12.35% |
| Q1 2023 Q2Q % growth | 5.309M 35.43% | 5.138M | 171K | 3.33% |
| Q4 2022 Q2Q % growth | 4.18M 488.73% | 8.648M | -4.468M | -51.67% |
| Q3 2022 Q2Q % growth | 6.63M 16,475.00% | 9.384M | -2.754M | -29.35% |
| Q2 2022 Q2Q % growth | 4.49M 1,503.57% | 8.861M | -4.371M | -49.33% |
| Q1 2022 Q2Q % growth | 3.92M 1,251.72% | 8.619M | -4.699M | -54.52% |
| Q4 2021 Q2Q % growth | 710K 184.00% | 165.75K | 544.25K | 328.36% |
| Q3 2021 Q2Q % growth | 40K -77.78% | 170.003K | -130.003K | -76.47% |
| Q2 2021 Q2Q % growth | 280K | 255K | 25K | 9.80% |
| Q1 2021 Q2Q % growth | 290K | 170.003K | 119.997K | 70.58% |
| Q4 2020 Q2Q % growth | 250K | 510K | -260K | -50.98% |
| Q3 2020 Q2Q % growth | 180K | 510K | -330K | -64.71% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.14% | 11.07% | -0.85% | 16.39% |
| Revenue | 0% | -12.25% | 0% | -0.18% |